首页|基于信号通路探讨清热方药调控溃疡性结肠炎"炎癌转化"的研究进展

基于信号通路探讨清热方药调控溃疡性结肠炎"炎癌转化"的研究进展

扫码查看
原文链接
  • 万方数据
溃疡性结肠炎(ulcerative colitis，UC)是一类原因不明的特发性、持续性的炎症性肠病，以腹痛、黏液脓血便及里急后重等临床表现为主要特征。本病多反复发作难愈，持续的炎症反应刺激肠黏膜导致肠道纤维化乃至癌变。中医认为UC病因离不开热邪。清热方药在治疗UC上具有疗效确定、不良反应轻等诸多优点，在临床运用极为广泛。既往基于UC慢性炎症及易于癌变的特点研究了诸多相关信号通路，控制"炎癌转化"亦是目前治疗UC的临床新途径、新方法。近些年关于清热方药干预UC的实验愈发增多，本文旨在总结清热方药从"炎癌转化"角度探讨UC治疗的6条通路，即TLR4/NF-κB信号通路、PI3K/AKT信号通路、MAPK信号通路、IL-6/JAK2/STAT3信号通路、Nrf2/NQO1信号通路、NLRP3/Caspase-1信号通路，以期为中医药治疗UC提供新思路。
Research progress on Heat-clearing Chinese Medicine regulates"inflammation-cancer transformation"of ulcerative colitis based on the signaling pathway
Ulcerative colitis(UC)is a kind of unexplained idiopathic and persistent inflammatory bowel dis-ease characterized by abdominal pain,mucous stool,bloody stool,and tenesmus.Chronic inflammation is a major feature of the colon in patients with UC.Traditional Chinese medicine believes that the etiology of UC is insepara-ble from heat pathogens.Heat-clearing Chinese Medicine has many advantages such as definite curative effects and mild side effects in the treatment of UC,so it is widely used in clinic.In the past,based on the characteristics of chronic inflammation and easy carcinogenesis of UC,many related signaling pathways have been studied,and the regulation of"inflammatory-cancer transformation"is also a new clinical method for the treatment of UC.In re-cent years,there has been more and more research on the mechanism of Heat-clearing Chinese Medicine on UC.The purpose of this paper is to summarize the six signaling pathways of UC treatment:TLR4/MyD88/NF-κB sig-naling pathway,PI3K/AKT signaling pathway,MAPK signaling pathway,IL-6/JAK2/STAT3 signaling path-way,Nrf2/NQO1 signaling pathway and NLRP3/Caspase-1 signaling pathway,in order to provide new ideas for clinical researchers in the treatment of UC with traditional Chinese medicine.

ulcerative colitisinflammatory responsecolorectal cancersignaling pathwayinflammatory bow-el disease

曾铖、顾思臻、黄诗韵、窦丹波

展开 >

上海中医药大学附属暖光医院传统医学科(上海,201203)

溃疡性结肠炎 炎症反应 结直肠癌 信号通路 炎症性肠病

国家自然科学基金项目上海市"科技创新行动计划"医学创新研究专项上海市2022年度"科技创新行动计划"生物医药科技支撑专项项目上海市卫健委"医苑新星"青年医学人才培养项目

8217428820Y2190190022S21903500沪卫计人事[2019]72号

2024

10.3969/j.issn.1671-038X.2024.02.16

中国中西医结合消化杂志
华中科技大学同济医学院,中国中西医结合学会消化系统疾病专业委员会,中华中医药学会脾胃病专业委员会

中国中西医结合消化杂志

CSTPCD
影响因子：1.363
ISSN：1671-038X
年,卷(期)：2024.32(2)
  • 52